In this 17-minute video, I explain my approach to exosomes. We discuss the objective measurements of aging that we use. In addition, we discuss the risks of placebo, nocebo, and unknown unknowns. The most important criterion is are you willing to take a chance on a logical intervention in the context of a patient-physician relationship?
Protected: Exosomes 3: a case of brain and neck trauma
There is no excerpt because this is a protected post.
Protected: Exosomes 2: Not inert
There is no excerpt because this is a protected post.
What proof do we have that adaptogens work?
Every time I speak with one of the 1,300 or so patients that take TA-65 or Recharge, we compare notes.
Pros and cons of a randomized trial
The problem of a randomized controlled trial is that it doesn’t explain mechanism or pertain to individual subjects
- Page 1 of 2
- 1
- 2